Year:  2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 

PQRS Measure

#144Oncology: Medical and Radiation - Plan of Care for Pain
 This measure may be submitted via Registry only

The following codes apply for this PQRS measure:

CPT Codes

CodeModifierPOSDescription
51720N/AN/ABladder instillation of anticarcinogenic agent (including retention time)
77427N/AN/ARadiation treatment management, 5 treatments
77431N/AN/ARadiation therapy management with complete course of therapy consisting of 1 or 2 fractions only
77432N/AN/AStereotactic radiation treatment management of cranial lesion(s) (complete course of treatment consisting of 1 session)
77435N/AN/AStereotactic body radiation therapy, treatment management, per treatment course, to 1 or more lesions, including image guidance, entire course not to exceed 5 fractions
77470N/AN/ASpecial treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)
96401N/AN/AChemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96402N/AN/AChemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96405N/AN/AChemotherapy administration; intralesional, up to and including 7 lesions
96406N/AN/AChemotherapy administration; intralesional, more than 7 lesions
96409N/AN/AChemotherapy administration; intravenous, push technique, single or initial substance/drug
96411N/AN/AChemotherapy administration; intravenous, push technique, each additional substance/drug (List separately in addition to code for primary procedure)
96413N/AN/AChemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415N/AN/AChemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
96416N/AN/AChemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump
96417N/AN/AChemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)
96420N/AN/AChemotherapy administration, intra-arterial; push technique
96422N/AN/AChemotherapy administration, intra-arterial; infusion technique, up to 1 hour
96423N/AN/AChemotherapy administration, intra-arterial; infusion technique, each additional hour (List separately in addition to code for primary procedure)
96425N/AN/AChemotherapy administration, intra-arterial; infusion technique, initiation of prolonged infusion (more than 8 hours), requiring the use of a portable or implantable pump
96440N/AN/AChemotherapy administration into pleural cavity, requiring and including thoracentesis
96446N/AN/AChemotherapy administration into the peritoneal cavity via implanted port or catheter
96450N/AN/AChemotherapy administration, into CNS (eg, intrathecal), requiring and including spinal puncture
96521N/AN/ARefilling and maintenance of portable pump
96522N/AN/ARefilling and maintenance of implantable pump or reservoir for drug delivery, systemic (eg, intravenous, intra-arterial)
96523N/AN/AIrrigation of implanted venous access device for drug delivery systems
96542N/AN/AChemotherapy injection, subarachnoid or intraventricular via subcutaneous reservoir, single or multiple agents
96549N/AN/AUnlisted chemotherapy procedure
99201N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
99202N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.
99203N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.
99204N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.
99205N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.
99212N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded.
99213N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.
99214N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.
99215N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.
1125FN/AN/APain severity quantified; pain present (COA) (ONC)

HCPCS Codes

CodeModifierPOSDescription
0521F8PN/A
0521FN/AN/A

ICD9 Codes

CodeModifierPOSDescription
140.0N/AN/AMalignant neoplasm of upper lip, vermilion border
140.1N/AN/AMalignant neoplasm of lower lip, vermilion border
140.3N/AN/AMalignant neoplasm of upper lip, inner aspect
140.4N/AN/AMalignant neoplasm of lower lip, inner aspect
140.5N/AN/AMalignant neoplasm of lip, unspecified, inner aspect
140.6N/AN/AMalignant neoplasm of commissure of lip
140.8N/AN/AMalignant neoplasm of other sites of lip
140.9N/AN/AMalignant neoplasm of lip, unspecified, vermilion border
141.0N/AN/AMalignant neoplasm of base of tongue
141.1N/AN/AMalignant neoplasm of dorsal surface of tongue
141.2N/AN/AMalignant neoplasm of tip and lateral border of tongue
141.3N/AN/AMalignant neoplasm of ventral surface of tongue
141.4N/AN/AMalignant neoplasm of anterior two-thirds of tongue, part unspecified
141.5N/AN/AMalignant neoplasm of junctional zone of tongue
141.6N/AN/AMalignant neoplasm of lingual tonsil
141.8N/AN/AMalignant neoplasm of other sites of tongue
141.9N/AN/AMalignant neoplasm of tongue, unspecified
142.0N/AN/AMalignant neoplasm of parotid gland
142.1N/AN/AMalignant neoplasm of submandibular gland
142.2N/AN/AMalignant neoplasm of sublingual gland
142.8N/AN/AMalignant neoplasm of other major salivary glands
142.9N/AN/AMalignant neoplasm of salivary gland, unspecified
143.0N/AN/AMalignant neoplasm of upper gum
143.1N/AN/AMalignant neoplasm of lower gum
143.8N/AN/AMalignant neoplasm of other sites of gum
143.9N/AN/AMalignant neoplasm of gum, unspecified
144.0N/AN/AMalignant neoplasm of anterior portion of floor of mouth
144.1N/AN/AMalignant neoplasm of lateral portion of floor of mouth
144.8N/AN/AMalignant neoplasm of other sites of floor of mouth
144.9N/AN/AMalignant neoplasm of floor of mouth, part unspecified
145.0N/AN/AMalignant neoplasm of cheek mucosa
145.1N/AN/AMalignant neoplasm of vestibule of mouth
145.2N/AN/AMalignant neoplasm of hard palate
145.3N/AN/AMalignant neoplasm of soft palate
145.4N/AN/AMalignant neoplasm of uvula
145.5N/AN/AMalignant neoplasm of palate, unspecified
145.6N/AN/AMalignant neoplasm of retromolar area
145.8N/AN/AMalignant neoplasm of other specified parts of mouth
145.9N/AN/AMalignant neoplasm of mouth, unspecified
146.0N/AN/AMalignant neoplasm of tonsil
146.1N/AN/AMalignant neoplasm of tonsillar fossa
146.2N/AN/AMalignant neoplasm of tonsillar pillars (anterior) (posterior)
146.3N/AN/AMalignant neoplasm of vallecula epiglottica
146.4N/AN/AMalignant neoplasm of anterior aspect of epiglottis
146.5N/AN/AMalignant neoplasm of junctional region of oropharynx
146.6N/AN/AMalignant neoplasm of lateral wall of oropharynx
146.7N/AN/AMalignant neoplasm of posterior wall of oropharynx
146.8N/AN/AMalignant neoplasm of other specified sites of oropharynx
146.9N/AN/AMalignant neoplasm of oropharynx, unspecified site
147.0N/AN/AMalignant neoplasm of superior wall of nasopharynx
147.1N/AN/AMalignant neoplasm of posterior wall of nasopharynx
147.2N/AN/AMalignant neoplasm of lateral wall of nasopharynx
147.3N/AN/AMalignant neoplasm of anterior wall of nasopharynx
147.8N/AN/AMalignant neoplasm of other specified sites of nasopharynx
147.9N/AN/AMalignant neoplasm of nasopharynx, unspecified site
148.0N/AN/AMalignant neoplasm of postcricoid region of hypopharynx
148.1N/AN/AMalignant neoplasm of pyriform sinus
148.2N/AN/AMalignant neoplasm of aryepiglottic fold, hypopharyngeal aspect
148.3N/AN/AMalignant neoplasm of posterior hypopharyngeal wall
148.8N/AN/AMalignant neoplasm of other specified sites of hypopharynx
148.9N/AN/AMalignant neoplasm of hypopharynx, unspecified site
149.0N/AN/AMalignant neoplasm of pharynx, unspecified
149.1N/AN/AMalignant neoplasm of waldeyer's ring
149.8N/AN/AMalignant neoplasm of other sites within the lip and oral cavity
149.9N/AN/AMalignant neoplasm of ill-defined sites within the lip and oral cavity
150.0N/AN/AMalignant neoplasm of cervical esophagus
150.1N/AN/AMalignant neoplasm of thoracic esophagus
150.2N/AN/AMalignant neoplasm of abdominal esophagus
150.3N/AN/AMalignant neoplasm of upper third of esophagus
150.4N/AN/AMalignant neoplasm of middle third of esophagus
150.5N/AN/AMalignant neoplasm of lower third of esophagus
150.8N/AN/AMalignant neoplasm of other specified part of esophagus
150.9N/AN/AMalignant neoplasm of esophagus, unspecified site
151.0N/AN/AMalignant neoplasm of cardia
151.1N/AN/AMalignant neoplasm of pylorus
151.2N/AN/AMalignant neoplasm of pyloric antrum
151.3N/AN/AMalignant neoplasm of fundus of stomach
151.4N/AN/AMalignant neoplasm of body of stomach
151.5N/AN/AMalignant neoplasm of lesser curvature of stomach, unspecified
151.6N/AN/AMalignant neoplasm of greater curvature of stomach, unspecified
151.8N/AN/AMalignant neoplasm of other specified sites of stomach
151.9N/AN/AMalignant neoplasm of stomach, unspecified site
152.0N/AN/AMalignant neoplasm of duodenum
152.1N/AN/AMalignant neoplasm of jejunum
152.2N/AN/AMalignant neoplasm of ileum
152.3N/AN/AMalignant neoplasm of Meckel's diverticulum
152.8N/AN/AMalignant neoplasm of other specified sites of small intestine
152.9N/AN/AMalignant neoplasm of small intestine, unspecified site
153.0N/AN/AMalignant neoplasm of hepatic flexure
153.1N/AN/AMalignant neoplasm of transverse colon
153.2N/AN/AMalignant neoplasm of descending colon
153.3N/AN/AMalignant neoplasm of sigmoid colon
153.4N/AN/AMalignant neoplasm of cecum
153.5N/AN/AMalignant neoplasm of appendix vermiformis
153.6N/AN/AMalignant neoplasm of ascending colon
153.7N/AN/AMalignant neoplasm of splenic flexure
153.8N/AN/AMalignant neoplasm of other specified sites of large intestine
153.9N/AN/AMalignant neoplasm of colon, unspecified site
154.0N/AN/AMalignant neoplasm of rectosigmoid junction
154.1N/AN/AMalignant neoplasm of rectum
154.2N/AN/AMalignant neoplasm of anal canal
154.3N/AN/AMalignant neoplasm of anus, unspecified site
154.8N/AN/AMalignant neoplasm of other sites of rectum, rectosigmoid junction, and anus
155.0N/AN/AMalignant neoplasm of liver, primary
155.1N/AN/AMalignant neoplasm of intrahepatic bile ducts
155.2N/AN/AMalignant neoplasm of liver, not specified as primary or secondary
156.0N/AN/AMalignant neoplasm of gallbladder
156.1N/AN/AMalignant neoplasm of extrahepatic bile ducts
156.2N/AN/AMalignant neoplasm of ampulla of vater
156.8N/AN/AMalignant neoplasm of other specified sites of gallbladder and extrahepatic bile ducts
156.9N/AN/AMalignant neoplasm of biliary tract, part unspecified site
157.0N/AN/AMalignant neoplasm of head of pancreas
157.1N/AN/AMalignant neoplasm of body of pancreas
157.2N/AN/AMalignant neoplasm of tail of pancreas
157.3N/AN/AMalignant neoplasm of pancreatic duct
157.4N/AN/AMalignant neoplasm of islets of langerhans
157.8N/AN/AMalignant neoplasm of other specified sites of pancreas
157.9N/AN/AMalignant neoplasm of pancreas, part unspecified
158.0N/AN/AMalignant neoplasm of retroperitoneum
158.8N/AN/AMalignant neoplasm of specified parts of peritoneum
158.9N/AN/AMalignant neoplasm of peritoneum, unspecified
159.0N/AN/AMalignant neoplasm of intestinal tract, part unspecified
159.1N/AN/AMalignant neoplasm of spleen, not elsewhere classified
159.8N/AN/AMalignant neoplasm of other sites of digestive system and intra-abdominal organs
159.9N/AN/AMalignant neoplasm of ill-defined sites within the digestive organs and peritoneum
160.0N/AN/AMalignant neoplasm of nasal cavities
160.1N/AN/AMalignant neoplasm of auditory tube, middle ear, and mastoid air cells
160.2N/AN/AMalignant neoplasm of maxillary sinus
160.3N/AN/AMalignant neoplasm of ethmoidal sinus
160.4N/AN/AMalignant neoplasm of frontal sinus
160.5N/AN/AMalignant neoplasm of sphenoidal sinus
160.8N/AN/AMalignant neoplasm of other accessory sinuses
160.9N/AN/AMalignant neoplasm of accessory sinus, unspecified
161.0N/AN/AMalignant neoplasm of glottis
161.1N/AN/AMalignant neoplasm of supraglottis
161.2N/AN/AMalignant neoplasm of subglottis
161.3N/AN/AMalignant neoplasm of laryngeal cartilages
161.8N/AN/AMalignant neoplasm of other specified sites of larynx
161.9N/AN/AMalignant neoplasm of larynx, unspecified
162.0N/AN/AMalignant neoplasm of trachea
162.2N/AN/AMalignant neoplasm of main bronchus
162.3N/AN/AMalignant neoplasm of upper lobe, bronchus or lung
162.4N/AN/AMalignant neoplasm of middle lobe, bronchus or lung
162.5N/AN/AMalignant neoplasm of lower lobe, bronchus or lung
162.8N/AN/AMalignant neoplasm of other parts of bronchus or lung
162.9N/AN/AMalignant neoplasm of bronchus and lung, unspecified
163.0N/AN/AMalignant neoplasm of parietal pleura
163.1N/AN/AMalignant neoplasm of visceral pleura
163.8N/AN/AMalignant neoplasm of other specified sites of pleura
163.9N/AN/AMalignant neoplasm of pleura, unspecified
164.0N/AN/AMalignant neoplasm of thymus
164.1N/AN/AMalignant neoplasm of heart
164.2N/AN/AMalignant neoplasm of anterior mediastinum
164.3N/AN/AMalignant neoplasm of posterior mediastinum
164.8N/AN/AMalignant neoplasm of other parts of mediastinum
164.9N/AN/AMalignant neoplasm of mediastinum, part unspecified
165.0N/AN/AMalignant neoplasm of upper respiratory tract, part unspecified
165.8N/AN/AMalignant neoplasm of other sites within the respiratory system and intrathoracic organs
165.9N/AN/AMalignant neoplasm of ill-defined sites within the respiratory system
170.0N/AN/AMalignant neoplasm of bones of skull and face, except mandible
170.1N/AN/AMalignant neoplasm of mandible
170.2N/AN/AMalignant neoplasm of vertebral column, excluding sacrum and coccyx
170.3N/AN/AMalignant neoplasm of ribs, sternum, and clavicle
170.4N/AN/AMalignant neoplasm of scapula and long bones of upper limb
170.5N/AN/AMalignant neoplasm of short bones of upper limb
170.6N/AN/AMalignant neoplasm of pelvic bones, sacrum, and coccyx
170.7N/AN/AMalignant neoplasm of long bones of lower limb
170.8N/AN/AMalignant neoplasm of short bones of lower limb
170.9N/AN/AMalignant neoplasm of bone and articular cartilage, site unspecified
171.0N/AN/AMalignant neoplasm of connective and other soft tissue of head, face, and neck
171.2N/AN/AMalignant neoplasm of connective and other soft tissue of upper limb, including shoulder
171.3N/AN/AMalignant neoplasm of connective and other soft tissue of lower limb, including hip
171.4N/AN/AMalignant neoplasm of connective and other soft tissue of thorax
171.5N/AN/AMalignant neoplasm of connective and other soft tissue of abdomen
171.6N/AN/AMalignant neoplasm of connective and other soft tissue of pelvis
171.7N/AN/AMalignant neoplasm of connective and other soft tissue of trunk, unspecified
171.8N/AN/AMalignant neoplasm of other specified sites of connective and other soft tissue
171.9N/AN/AMalignant neoplasm of connective and other soft tissue, site unspecified
172.0N/AN/AMalignant melanoma of skin of lip
172.1N/AN/AMalignant melanoma of skin of eyelid, including canthus
172.2N/AN/AMalignant melanoma of skin of ear and external auditory canal
172.3N/AN/AMalignant melanoma of skin of other and unspecified parts of face
172.4N/AN/AMalignant melanoma of skin of scalp and neck
172.5N/AN/AMalignant melanoma of skin of trunk, except scrotum
172.6N/AN/AMalignant melanoma of skin of upper limb, including shoulder
172.7N/AN/AMalignant melanoma of skin of lower limb, including hip
172.8N/AN/AMalignant melanoma of other specified sites of skin
172.9N/AN/AMelanoma of skin, site unspecified
173.00N/AN/AUnspecified malignant neoplasm of skin of lip
173.01N/AN/ABasal cell carcinoma of skin of lip
173.02N/AN/ASquamous cell carcinoma of skin of lip
173.09N/AN/AOther specified malignant neoplasm of skin of lip
173.10N/AN/AUnspecified malignant neoplasm of eyelid, including canthus
173.11N/AN/ABasal cell carcinoma of eyelid, including canthus
173.12N/AN/ASquamous cell carcinoma of eyelid, including canthus
173.19N/AN/AOther specified malignant neoplasm of eyelid, including canthus
173.20N/AN/AUnspecified malignant neoplasm of skin of ear and external auditory canal
173.21N/AN/ABasal cell carcinoma of skin of ear and external auditory canal
173.22N/AN/ASquamous cell carcinoma of skin of ear and external auditory canal
173.29N/AN/AOther specified malignant neoplasm of skin of ear and external auditory canal
173.30N/AN/AUnspecified malignant neoplasm of skin of other and unspecified parts of face
173.31N/AN/ABasal cell carcinoma of skin of other and unspecified parts of face
173.32N/AN/ASquamous cell carcinoma of skin of other and unspecified parts of face
173.39N/AN/AOther specified malignant neoplasm of skin of other and unspecified parts of face
173.40N/AN/AUnspecified malignant neoplasm of scalp and skin of neck
173.41N/AN/ABasal cell carcinoma of scalp and skin of neck
173.42N/AN/ASquamous cell carcinoma of scalp and skin of neck
173.49N/AN/AOther specified malignant neoplasm of scalp and skin of neck
173.50N/AN/AUnspecified malignant neoplasm of skin of trunk, except scrotum
173.51N/AN/ABasal cell carcinoma of skin of trunk, except scrotum
173.52N/AN/ASquamous cell carcinoma of skin of trunk, except scrotum
173.59N/AN/AOther specified malignant neoplasm of skin of trunk, except scrotum
173.60N/AN/AUnspecified malignant neoplasm of skin of upper limb, including shoulder
173.61N/AN/ABasal cell carcinoma of skin of upper limb, including shoulder
173.62N/AN/ASquamous cell carcinoma of skin of upper limb, including shoulder
173.69N/AN/AOther specified malignant neoplasm of skin of upper limb, including shoulder
173.70N/AN/AUnspecified malignant neoplasm of skin of lower limb, including hip
173.71N/AN/ABasal cell carcinoma of skin of lower limb, including hip
173.72N/AN/ASquamous cell carcinoma of skin of lower limb, including hip
173.79N/AN/AOther specified malignant neoplasm of skin of lower limb, including hip
173.80N/AN/AUnspecified malignant neoplasm of other specified sites of skin
173.81N/AN/ABasal cell carcinoma of other specified sites of skin
173.82N/AN/ASquamous cell carcinoma of other specified sites of skin
173.89N/AN/AOther specified malignant neoplasm of other specified sites of skin
173.90N/AN/AUnspecified malignant neoplasm of skin, site unspecified
173.91N/AN/ABasal cell carcinoma of skin, site unspecified
173.92N/AN/ASquamous cell carcinoma of skin, site unspecified
173.99N/AN/AOther specified malignant neoplasm of skin, site unspecified
174.0N/AN/AMalignant neoplasm of nipple and areola of female breast
174.1N/AN/AMalignant neoplasm of central portion of female breast
174.2N/AN/AMalignant neoplasm of upper-inner quadrant of female breast
174.3N/AN/AMalignant neoplasm of lower-inner quadrant of female breast
174.4N/AN/AMalignant neoplasm of upper-outer quadrant of female breast
174.5N/AN/AMalignant neoplasm of lower-outer quadrant of female breast
174.6N/AN/AMalignant neoplasm of axillary tail of female breast
174.8N/AN/AMalignant neoplasm of other specified sites of female breast
174.9N/AN/AMalignant neoplasm of breast (female), unspecified
175.0N/AN/AMalignant neoplasm of nipple and areola of male breast
175.9N/AN/AMalignant neoplasm of other and unspecified sites of male breast
176.0N/AN/AKaposi's sarcoma, skin
176.1N/AN/AKaposi's sarcoma, soft tissue
176.2N/AN/AKaposi's sarcoma, palate
176.3N/AN/AKaposi's sarcoma, gastrointestinal sites
176.4N/AN/AKaposi's sarcoma, lung
176.5N/AN/AKaposi's sarcoma, lymph nodes
176.8N/AN/AKaposi's sarcoma, other specified sites
176.9N/AN/AKaposi's sarcoma, unspecified site
179N/AN/AMalignant neoplasm of uterus, part unspecified
180.0N/AN/AMalignant neoplasm of endocervix
180.1N/AN/AMalignant neoplasm of exocervix
180.8N/AN/AMalignant neoplasm of other specified sites of cervix
180.9N/AN/AMalignant neoplasm of cervix uteri, unspecified site
181N/AN/AMalignant neoplasm of placenta
182.0N/AN/AMalignant neoplasm of corpus uteri, except isthmus
182.1N/AN/AMalignant neoplasm of isthmus
182.8N/AN/AMalignant neoplasm of other specified sites of body of uterus
183.0N/AN/AMalignant neoplasm of ovary
183.2N/AN/AMalignant neoplasm of fallopian tube
183.3N/AN/AMalignant neoplasm of broad ligament of uterus
183.4N/AN/AMalignant neoplasm of parametrium
183.5N/AN/AMalignant neoplasm of round ligament of uterus
183.8N/AN/AMalignant neoplasm of other specified sites of uterine adnexa
183.9N/AN/AMalignant neoplasm of uterine adnexa, unspecified site
184.0N/AN/AMalignant neoplasm of vagina
184.1N/AN/AMalignant neoplasm of labia majora
184.2N/AN/AMalignant neoplasm of labia minora
184.3N/AN/AMalignant neoplasm of clitoris
184.4N/AN/AMalignant neoplasm of vulva, unspecified site
184.8N/AN/AMalignant neoplasm of other specified sites of female genital organs
184.9N/AN/AMalignant neoplasm of female genital organ, site unspecified
185N/AN/AMalignant neoplasm of prostate
186.0N/AN/AMalignant neoplasm of undescended testis
186.9N/AN/AMalignant neoplasm of other and unspecified testis
187.1N/AN/AMalignant neoplasm of prepuce
187.2N/AN/AMalignant neoplasm of glans penis
187.3N/AN/AMalignant neoplasm of body of penis
187.4N/AN/AMalignant neoplasm of penis, part unspecified
187.5N/AN/AMalignant neoplasm of epididymis
187.6N/AN/AMalignant neoplasm of spermatic cord
187.7N/AN/AMalignant neoplasm of scrotum
187.8N/AN/AMalignant neoplasm of other specified sites of male genital organs
187.9N/AN/AMalignant neoplasm of male genital organ, site unspecified
188.0N/AN/AMalignant neoplasm of trigone of urinary bladder
188.1N/AN/AMalignant neoplasm of dome of urinary bladder
188.2N/AN/AMalignant neoplasm of lateral wall of urinary bladder
188.3N/AN/AMalignant neoplasm of anterior wall of urinary bladder
188.4N/AN/AMalignant neoplasm of posterior wall of urinary bladder
188.5N/AN/AMalignant neoplasm of bladder neck
188.6N/AN/AMalignant neoplasm of ureteric orifice
188.7N/AN/AMalignant neoplasm of urachus
188.8N/AN/AMalignant neoplasm of other specified sites of bladder
188.9N/AN/AMalignant neoplasm of bladder, part unspecified
189.0N/AN/AMalignant neoplasm of kidney, except pelvis
189.1N/AN/AMalignant neoplasm of renal pelvis
189.2N/AN/AMalignant neoplasm of ureter
189.3N/AN/AMalignant neoplasm of urethra
189.4N/AN/AMalignant neoplasm of paraurethral glands
189.8N/AN/AMalignant neoplasm of other specified sites of urinary organs
189.9N/AN/AMalignant neoplasm of urinary organ, site unspecified
190.0N/AN/AMalignant neoplasm of eyeball, except conjunctiva, cornea, retina, and choroid
190.1N/AN/AMalignant neoplasm of orbit
190.2N/AN/AMalignant neoplasm of lacrimal gland
190.3N/AN/AMalignant neoplasm of conjunctiva
190.4N/AN/AMalignant neoplasm of cornea
190.5N/AN/AMalignant neoplasm of retina
190.6N/AN/AMalignant neoplasm of choroid
190.7N/AN/AMalignant neoplasm of lacrimal duct
190.8N/AN/AMalignant neoplasm of other specified sites of eye
190.9N/AN/AMalignant neoplasm of eye, part unspecified
191.0N/AN/AMalignant neoplasm of cerebrum, except lobes and ventricles
191.1N/AN/AMalignant neoplasm of frontal lobe
191.2N/AN/AMalignant neoplasm of temporal lobe
191.3N/AN/AMalignant neoplasm of parietal lobe
191.4N/AN/AMalignant neoplasm of occipital lobe
191.5N/AN/AMalignant neoplasm of ventricles
191.6N/AN/AMalignant neoplasm of cerebellum nos
191.7N/AN/AMalignant neoplasm of brain stem
191.8N/AN/AMalignant neoplasm of other parts of brain
191.9N/AN/AMalignant neoplasm of brain, unspecified
192.0N/AN/AMalignant neoplasm of cranial nerves
192.1N/AN/AMalignant neoplasm of cerebral meninges
192.2N/AN/AMalignant neoplasm of spinal cord
192.3N/AN/AMalignant neoplasm of spinal meninges
192.8N/AN/AMalignant neoplasm of other specified sites of nervous system
192.9N/AN/AMalignant neoplasm of nervous system, part unspecified
193N/AN/AMalignant neoplasm of thyroid gland
194.0N/AN/AMalignant neoplasm of adrenal gland
194.1N/AN/AMalignant neoplasm of parathyroid gland
194.3N/AN/AMalignant neoplasm of pituitary gland and craniopharyngeal duct
194.4N/AN/AMalignant neoplasm of pineal gland
194.5N/AN/AMalignant neoplasm of carotid body
194.6N/AN/AMalignant neoplasm of aortic body and other paraganglia
194.8N/AN/AMalignant neoplasm of other endocrine glands and related structures
194.9N/AN/AMalignant neoplasm of endocrine gland, site unspecified
195.0N/AN/AMalignant neoplasm of head, face, and neck
195.1N/AN/AMalignant neoplasm of thorax
195.2N/AN/AMalignant neoplasm of abdomen
195.3N/AN/AMalignant neoplasm of pelvis
195.4N/AN/AMalignant neoplasm of upper limb
195.5N/AN/AMalignant neoplasm of lower limb
195.8N/AN/AMalignant neoplasm of other specified sites
196.0N/AN/ASecondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck
196.1N/AN/ASecondary and unspecified malignant neoplasm of intrathoracic lymph nodes
196.2N/AN/ASecondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
196.3N/AN/ASecondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb
196.5N/AN/ASecondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb
196.6N/AN/ASecondary and unspecified malignant neoplasm of intrapelvic lymph nodes
196.8N/AN/ASecondary and unspecified malignant neoplasm of lymph nodes of multiple sites
196.9N/AN/ASecondary and unspecified malignant neoplasm of lymph nodes, site unspecified
197.0N/AN/ASecondary malignant neoplasm of lung
197.1N/AN/ASecondary malignant neoplasm of mediastinum
197.2N/AN/ASecondary malignant neoplasm of pleura
197.3N/AN/ASecondary malignant neoplasm of other respiratory organs
197.4N/AN/ASecondary malignant neoplasm of small intestine including duodenum
197.5N/AN/ASecondary malignant neoplasm of large intestine and rectum
197.6N/AN/ASecondary malignant neoplasm of retroperitoneum and peritoneum
197.7N/AN/AMalignant neoplasm of liver, secondary
197.8N/AN/ASecondary malignant neoplasm of other digestive organs and spleen
198.0N/AN/ASecondary malignant neoplasm of kidney
198.1N/AN/ASecondary malignant neoplasm of other urinary organs
198.2N/AN/ASecondary malignant neoplasm of skin
198.3N/AN/ASecondary malignant neoplasm of brain and spinal cord
198.4N/AN/ASecondary malignant neoplasm of other parts of nervous system
198.5N/AN/ASecondary malignant neoplasm of bone and bone marrow
198.6N/AN/ASecondary malignant neoplasm of ovary
198.7N/AN/ASecondary malignant neoplasm of adrenal gland
198.81N/AN/ASecondary malignant neoplasm of breast
198.82N/AN/ASecondary malignant neoplasm of genital organs
198.89N/AN/ASecondary malignant neoplasm of other specified sites
199.0N/AN/ADisseminated malignant neoplasm without specification of site
199.1N/AN/AOther malignant neoplasm without specification of site
199.2N/AN/AMalignant neoplasm associated with transplant organ
200.00N/AN/AReticulosarcoma, unspecified site, extranodal and solid organ sites
200.01N/AN/AReticulosarcoma, lymph nodes of head, face, and neck
200.02N/AN/AReticulosarcoma, intrathoracic lymph nodes
200.03N/AN/AReticulosarcoma, intra-abdominal lymph nodes
200.04N/AN/AReticulosarcoma, lymph nodes of axilla and upper limb
200.05N/AN/AReticulosarcoma, lymph nodes of inguinal region and lower limb
200.06N/AN/AReticulosarcoma, intrapelvic lymph nodes
200.07N/AN/AReticulosarcoma, spleen
200.08N/AN/AReticulosarcoma, lymph nodes of multiple sites
200.10N/AN/ALymphosarcoma, unspecified site, extranodal and solid organ sites
200.11N/AN/ALymphosarcoma, lymph nodes of head, face, and neck
200.12N/AN/ALymphosarcoma, intrathoracic lymph nodes
200.13N/AN/ALymphosarcoma, intra-abdominal lymph nodes
200.14N/AN/ALymphosarcoma, lymph nodes of axilla and upper limb
200.15N/AN/ALymphosarcoma, lymph nodes of inguinal region and lower limb
200.16N/AN/ALymphosarcoma, intrapelvic lymph nodes
200.17N/AN/ALymphosarcoma, spleen
200.18N/AN/ALymphosarcoma, lymph nodes of multiple sites
200.20N/AN/ABurkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites
200.21N/AN/ABurkitt's tumor or lymphoma, lymph nodes of head, face, and neck
200.22N/AN/ABurkitt's tumor or lymphoma, intrathoracic lymph nodes
200.23N/AN/ABurkitt's tumor or lymphoma, intra-abdominal lymph nodes
200.24N/AN/ABurkitt's tumor or lymphoma, lymph nodes of axilla and upper limb
200.25N/AN/ABurkitt's tumor or lymphoma, lymph nodes of inguinal region and lower limb
200.26N/AN/ABurkitt's tumor or lymphoma, intrapelvic lymph nodes
200.27N/AN/ABurkitt's tumor or lymphoma, spleen
200.28N/AN/ABurkitt's tumor or lymphoma, lymph nodes of multiple sites
200.30N/AN/AMarginal zone lymphoma, unspecified site, extranodal and solid organ sites
200.31N/AN/AMarginal zone lymphoma, lymph nodes of head, face, and neck
200.32N/AN/AMarginal zone lymphoma, intrathoracic lymph nodes
200.33N/AN/AMarginal zone lymphoma, intraabdominal lymph nodes
200.34N/AN/AMarginal zone lymphoma, lymph nodes of axilla and upper limb
200.35N/AN/AMarginal zone lymphoma, lymph nodes of inguinal region and lower limb
200.36N/AN/AMarginal zone lymphoma, intrapelvic lymph nodes
200.37N/AN/AMarginal zone lymphoma, spleen
200.38N/AN/AMarginal zone lymphoma, lymph nodes of multiple sites
200.40N/AN/AMantle cell lymphoma, unspecified site, extranodal and solid organ sites
200.41N/AN/AMantle cell lymphoma, lymph nodes of head, face, and neck
200.42N/AN/AMantle cell lymphoma, intrathoracic lymph nodes
200.43N/AN/AMantle cell lymphoma, intra-abdominal lymph nodes
200.44N/AN/AMantle cell lymphoma, lymph nodes of axilla and upper limb
200.45N/AN/AMantle cell lymphoma, lymph nodes of inguinal region and lower limb
200.46N/AN/AMantle cell lymphoma, intrapelvic lymph nodes
200.47N/AN/AMantle cell lymphoma, spleen
200.48N/AN/AMantle cell lymphoma, lymph nodes of multiple sites
200.50N/AN/APrimary central nervous system lymphoma, unspecified site, extranodal and solid organ sites
200.51N/AN/APrimary central nervous system lymphoma, lymph nodes of head, face, and neck
200.52N/AN/APrimary central nervous system lymphoma, intrathoracic lymph nodes
200.53N/AN/APrimary central nervous system lymphoma, intra-abdominal lymph nodes
200.54N/AN/APrimary central nervous system lymphoma, lymph nodes of axilla and upper limb
200.55N/AN/APrimary central nervous system lymphoma, lymph nodes of inguinal region and lower limb
200.56N/AN/APrimary central nervous system lymphoma, intrapelvic lymph nodes
200.57N/AN/APrimary central nervous system lymphoma, spleen
200.58N/AN/APrimary central nervous system lymphoma, lymph nodes of multiple sites
200.60N/AN/AAnaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites
200.61N/AN/AAnaplastic large cell lymphoma, lymph nodes of head, face, and neck
200.62N/AN/AAnaplastic large cell lymphoma, intrathoracic lymph nodes
200.63N/AN/AAnaplastic large cell lymphoma, intra-abdominal lymph nodes
200.64N/AN/AAnaplastic large cell lymphoma, lymph nodes of axilla and upper limb
200.65N/AN/AAnaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb
200.66N/AN/AAnaplastic large cell lymphoma, intrapelvic lymph nodes
200.67N/AN/AAnaplastic large cell lymphoma, spleen
200.68N/AN/AAnaplastic large cell lymphoma, lymph nodes of multiple sites
200.70N/AN/ALarge cell lymphoma, unspecified site, extranodal and solid organ sites
200.71N/AN/ALarge cell lymphoma, lymph nodes of head, face, and neck
200.72N/AN/ALarge cell lymphoma, intrathoracic lymph nodes
200.73N/AN/ALarge cell lymphoma, intra-abdominal lymph nodes
200.74N/AN/ALarge cell lymphoma, lymph nodes of axilla and upper limb
200.75N/AN/ALarge cell lymphoma, lymph nodes of inguinal region and lower limb
200.76N/AN/ALarge cell lymphoma, intrapelvic lymph nodes
200.77N/AN/ALarge cell lymphoma, spleen
200.78N/AN/ALarge cell lymphoma, lymph nodes of multiple sites
200.80N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, unspecified site, extranodal and solid organ sites
200.81N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, lymph nodes of head, face, and neck
200.82N/AN/AOther named variants of lymphosarcoma and reticulosarcoma,intrathoracic lymph nodes
200.83N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, intra-abdominal lymph nodes
200.84N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, lymph nodes of axilla and upper limb
200.85N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, lymph nodes of inguinal region and lower limb
200.86N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, intrapelvic lymph nodes
200.87N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, spleen
200.88N/AN/AOther named variants of lymphosarcoma and reticulosarcoma, lymph nodes of multiple sites
201.00N/AN/AHodgkin's paragranuloma, unspecified site, extranodal and solid organ sites
201.01N/AN/AHodgkin's paragranuloma, lymph nodes of head, face, and neck
201.02N/AN/AHodgkin's paragranuloma, intrathoracic lymph nodes
201.03N/AN/AHodgkin's paragranuloma, intra-abdominal lymph nodes
201.04N/AN/AHodgkin's paragranuloma, lymph nodes of axilla and upper limb
201.05N/AN/AHodgkin's paragranuloma, lymph nodes of inguinal region and lower limb
201.06N/AN/AHodgkin's paragranuloma, intrapelvic lymph nodes
201.07N/AN/AHodgkin's paragranuloma, spleen
201.08N/AN/AHodgkin's paragranuloma, lymph nodes of multiple sites
201.10N/AN/AHodgkin's granuloma, unspecified site, extranodal and solid organ sites
201.11N/AN/AHodgkin's granuloma, lymph nodes of head, face, and neck
201.12N/AN/AHodgkin's granuloma, intrathoracic lymph nodes
201.13N/AN/AHodgkin's granuloma, intra-abdominal lymph nodes
201.14N/AN/AHodgkin's granuloma, lymph nodes of axilla and upper limb
201.15N/AN/AHodgkin's granuloma, lymph nodes of inguinal region and lower limb
201.16N/AN/AHodgkin's granuloma, intrapelvic lymph nodes
201.17N/AN/AHodgkin's granuloma, spleen
201.18N/AN/AHodgkin's granuloma, lymph nodes of multiple sites
201.20N/AN/AHodgkin's sarcoma, unspecified site, extranodal and solid organ sites
201.21N/AN/AHodgkin's sarcoma, lymph nodes of head, face, and neck
201.22N/AN/AHodgkin's sarcoma, intrathoracic lymph nodes
201.23N/AN/AHodgkin's sarcoma, intra-abdominal lymph nodes
201.24N/AN/AHodgkin's sarcoma, lymph nodes of axilla and upper limb
201.25N/AN/AHodgkin's sarcoma, lymph nodes of inguinal region and lower limb
201.26N/AN/AHodgkin's sarcoma, intrapelvic lymph nodes
201.27N/AN/AHodgkin's sarcoma, spleen
201.28N/AN/AHodgkin's sarcoma, lymph nodes of multiple sites
201.40N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites
201.41N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck
201.42N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph nodes
201.43N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, intra-abdominal lymph nodes
201.44N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla and upper limb
201.45N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of inguinal region and lower limb
201.46N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph nodes
201.47N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, spleen
201.48N/AN/AHodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of multiple sites
201.50N/AN/AHodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites
201.51N/AN/AHodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck
201.52N/AN/AHodgkin's disease, nodular sclerosis, intrathoracic lymph nodes
201.53N/AN/AHodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes
201.54N/AN/AHodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb
201.55N/AN/AHodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower limb
201.56N/AN/AHodgkin's disease, nodular sclerosis, intrapelvic lymph nodes
201.57N/AN/AHodgkin's disease, nodular sclerosis, spleen
201.58N/AN/AHodgkin's disease, nodular sclerosis, lymph nodes of multiple sites
201.60N/AN/AHodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ sites
201.61N/AN/AHodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck
201.62N/AN/AHodgkin's disease, mixed cellularity, intrathoracic lymph nodes
201.63N/AN/AHodgkin's disease, mixed cellularity, intra-abdominal lymph nodes
201.64N/AN/AHodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb
201.65N/AN/AHodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower limb
201.66N/AN/AHodgkin's disease, mixed cellularity, intrapelvic lymph nodes
201.67N/AN/AHodgkin's disease, mixed cellularity, spleen
201.68N/AN/AHodgkin's disease, mixed cellularity, lymph nodes of multiple sites
201.70N/AN/AHodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites
201.71N/AN/AHodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck
201.72N/AN/AHodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes
201.73N/AN/AHodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes
201.74N/AN/AHodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb
201.75N/AN/AHodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and lower limb
201.76N/AN/AHodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes
201.77N/AN/AHodgkin's disease, lymphocytic depletion, spleen
201.78N/AN/AHodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites
201.90N/AN/AHodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites
201.91N/AN/AHodgkin's disease, unspecified type, lymph nodes of head, face, and neck
201.92N/AN/AHodgkin's disease, unspecified type, intrathoracic lymph nodes
201.93N/AN/AHodgkin's disease, unspecified type, intra-abdominal lymph nodes
201.94N/AN/AHodgkin's disease, unspecified type, lymph nodes of axilla and upper limb
201.95N/AN/AHodgkin's disease, unspecified type, lymph nodes of inguinal region and lower limb
201.96N/AN/AHodgkin's disease, unspecified type, intrapelvic lymph nodes
201.97N/AN/AHodgkin's disease, unspecified type, spleen
201.98N/AN/AHodgkin's disease, unspecified type, lymph nodes of multiple sites
202.00N/AN/ANodular lymphoma, unspecified site, extranodal and solid organ sites
202.01N/AN/ANodular lymphoma, lymph nodes of head, face, and neck
202.02N/AN/ANodular lymphoma, intrathoracic lymph nodes
202.03N/AN/ANodular lymphoma, intra-abdominal lymph nodes
202.04N/AN/ANodular lymphoma, lymph nodes of axilla and upper limb
202.05N/AN/ANodular lymphoma, lymph nodes of inguinal region and lower limb
202.06N/AN/ANodular lymphoma, intrapelvic lymph nodes
202.07N/AN/ANodular lymphoma, spleen
202.08N/AN/ANodular lymphoma, lymph nodes of multiple sites
202.10N/AN/AMycosis fungoides, unspecified site, extranodal and solid organ sites
202.11N/AN/AMycosis fungoides, lymph nodes of head, face, and neck
202.12N/AN/AMycosis fungoides, intrathoracic lymph nodes
202.13N/AN/AMycosis fungoides, intra-abdominal lymph nodes
202.14N/AN/AMycosis fungoides, lymph nodes of axilla and upper limb
202.15N/AN/AMycosis fungoides, lymph nodes of inguinal region and lower limb
202.16N/AN/AMycosis fungoides, intrapelvic lymph nodes
202.17N/AN/AMycosis fungoides, spleen
202.18N/AN/AMycosis fungoides, lymph nodes of multiple sites
202.20N/AN/ASezary's disease, unspecified site, extranodal and solid organ sites
202.21N/AN/ASezary's disease, lymph nodes of head, face, and neck
202.22N/AN/ASezary's disease, intrathoracic lymph nodes
202.23N/AN/ASezary's disease, intra-abdominal lymph nodes
202.24N/AN/ASezary's disease, lymph nodes of axilla and upper limb
202.25N/AN/ASezary's disease, lymph nodes of inguinal region and lower limb
202.26N/AN/ASezary's disease, intrapelvic lymph nodes
202.27N/AN/ASezary's disease, spleen
202.28N/AN/ASezary's disease, lymph nodes of multiple sites
202.30N/AN/AMalignant histiocytosis, unspecified site, extranodal and solid organ sites
202.31N/AN/AMalignant histiocytosis, lymph nodes of head, face, and neck
202.32N/AN/AMalignant histiocytosis, intrathoracic lymph nodes
202.33N/AN/AMalignant histiocytosis, intra-abdominal lymph nodes
202.34N/AN/AMalignant histiocytosis, lymph nodes of axilla and upper limb
202.35N/AN/AMalignant histiocytosis, lymph nodes of inguinal region and lower limb
202.36N/AN/AMalignant histiocytosis, intrapelvic lymph nodes
202.37N/AN/AMalignant histiocytosis, spleen
202.38N/AN/AMalignant histiocytosis, lymph nodes of multiple sites
202.40N/AN/ALeukemic reticuloendotheliosis, unspecified site, extranodal and solid organ sites
202.41N/AN/ALeukemic reticuloendotheliosis, lymph nodes of head, face, and neck
202.42N/AN/ALeukemic reticuloendotheliosis, intrathoracic lymph nodes
202.43N/AN/ALeukemic reticuloendotheliosis, intra-abdominal lymph nodes
202.44N/AN/ALeukemic reticuloendotheliosis, lymph nodes of axilla and upper arm
202.45N/AN/ALeukemic reticuloendotheliosis, lymph nodes of inguinal region and lower limb
202.46N/AN/ALeukemic reticuloendotheliosis, intrapelvic lymph nodes
202.47N/AN/ALeukemic reticuloendotheliosis, spleen
202.48N/AN/ALeukemic reticuloendotheliosis, lymph nodes of multiple sites
202.50N/AN/ALetterer-siwe disease, unspecified site, extranodal and solid organ sites
202.51N/AN/ALetterer-siwe disease, lymph nodes of head, face, and neck
202.52N/AN/ALetterer-siwe disease, intrathoracic lymph nodes
202.53N/AN/ALetterer-siwe disease, intra-abdominal lymph nodes
202.54N/AN/ALetterer-siwe disease, lymph nodes of axilla and upper limb
202.55N/AN/ALetterer-siwe disease, lymph nodes of inguinal region and lower limb
202.56N/AN/ALetterer-siwe disease, intrapelvic lymph nodes
202.57N/AN/ALetterer-siwe disease, spleen
202.58N/AN/ALetterer-siwe disease, lymph nodes of multiple sites
202.60N/AN/AMalignant mast cell tumors, unspecified site, extranodal and solid organ sites
202.61N/AN/AMalignant mast cell tumors, lymph nodes of head, face, and neck
202.62N/AN/AMalignant mast cell tumors, intrathoracic lymph nodes
202.63N/AN/AMalignant mast cell tumors, intra-abdominal lymph nodes
202.64N/AN/AMalignant mast cell tumors, lymph nodes of axilla and upper limb
202.65N/AN/AMalignant mast cell tumors, lymph nodes of inguinal region and lower limb
202.66N/AN/AMalignant mast cell tumors, intrapelvic lymph nodes
202.67N/AN/AMalignant mast cell tumors, spleen
202.68N/AN/AMalignant mast cell tumors, lymph nodes of multiple sites
202.70N/AN/APeripheral T cell lymphoma, unspecified site, extranodal and solid organ sites
202.71N/AN/APeripheral T cell lymphoma, lymph nodes of head, face, and neck
202.72N/AN/APeripheral T cell lymphoma, intrathoracic lymph nodes
202.73N/AN/APeripheral T cell lymphoma, intra-abdominal lymph nodes
202.74N/AN/APeripheral T cell lymphoma, lymph nodes of axilla and upper limb
202.75N/AN/APeripheral T cell lymphoma, lymph nodes of inguinal region and lower limb
202.76N/AN/APeripheral T cell lymphoma, intrapelvic lymph nodes
202.77N/AN/APeripheral T cell lymphoma, spleen
202.78N/AN/APeripheral T cell lymphoma, lymph nodes of multiple sites
202.80N/AN/AOther malignant lymphomas, unspecified site, extranodal and solid organ sites
202.81N/AN/AOther malignant lymphomas, lymph nodes of head, face, and neck
202.82N/AN/AOther malignant lymphomas, intrathoracic lymph nodes
202.83N/AN/AOther malignant lymphomas, intra-abdominal lymph nodes
202.84N/AN/AOther malignant lymphomas, lymph nodes of axilla and upper limb
202.85N/AN/AOther malignant lymphomas, lymph nodes of inguinal region and lower limb
202.86N/AN/AOther malignant lymphomas, intrapelvic lymph nodes
202.87N/AN/AOther malignant lymphomas, spleen
202.88N/AN/AOther malignant lymphomas, lymph nodes of multiple sites
202.90N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites
202.91N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of head, face, and neck
202.92N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrathoracic lymph nodes
202.93N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intra-abdominal lymph nodes
202.94N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of axilla and upper limb
202.95N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of inguinal region and lower limb
202.96N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrapelvic lymph nodes
202.97N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, spleen
202.98N/AN/AOther and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of multiple sites
203.00N/AN/AMultiple myeloma, without mention of having achieved remission
203.01N/AN/AMultiple myeloma, in remission
203.02N/AN/AMultiple myeloma, in relapse
203.10N/AN/APlasma cell leukemia, without mention of having achieved remission
203.11N/AN/APlasma cell leukemia, in remission
203.12N/AN/APlasma cell leukemia, in relapse
203.80N/AN/AOther immunoproliferative neoplasms, without mention of having achieved remission
203.81N/AN/AOther immunoproliferative neoplasms, in remission
203.82N/AN/AOther immunoproliferative neoplasms, in relapse
204.00N/AN/AAcute lymphoid leukemia, without mention of having achieved remission
204.01N/AN/AAcute lymphoid leukemia, in remission
204.02N/AN/AAcute lymphoid leukemia, in relapse
204.10N/AN/AChronic lymphoid leukemia, without mention of having achieved remission
204.11N/AN/AChronic lymphoid leukemia, in remission
204.12N/AN/AChronic lymphoid leukemia, in relapse
204.20N/AN/ASubacute lymphoid leukemia, without mention of having achieved remission
204.21N/AN/ASubacute lymphoid leukemia, in remission
204.22N/AN/ASubacute lymphoid leukemia, in relapse
204.80N/AN/AOther lymphoid leukemia, without mention of having achieved remission
204.81N/AN/AOther lymphoid leukemia, in remission
204.82N/AN/AOther lymphoid leukemia, in relapse
204.90N/AN/AUnspecified lymphoid leukemia, without mention of having achieved remission
204.91N/AN/AUnspecified lymphoid leukemia, in remission
204.92N/AN/AUnspecified lymphoid leukemia, in relapse
205.00N/AN/AAcute myeloid leukemia, without mention of having achieved remission
205.01N/AN/AAcute myeloid leukemia, in remission
205.02N/AN/AAcute myeloid leukemia, in relapse
205.10N/AN/AChronic myeloid leukemia, without mention of having achieved remission
205.11N/AN/AChronic myeloid leukemia, in remission
205.12N/AN/AChronic myeloid leukemia, in relapse
205.20N/AN/ASubacute myeloid leukemia, without mention of having achieved remission
205.21N/AN/ASubacute myeloid leukemia,in remission
205.22N/AN/ASubacute myeloid leukemia, in relapse
205.30N/AN/AMyeloid sarcoma, without mention of having achieved remission
205.31N/AN/AMyeloid sarcoma, in remission
205.32N/AN/AMyeloid sarcoma, in relapse
205.80N/AN/AOther myeloid leukemia, without mention of having achieved remission
205.81N/AN/AOther myeloid leukemia, in remission
205.82N/AN/AOther myeloid leukemia, in relapse
205.90N/AN/AUnspecified myeloid leukemia, without mention of having achieved remission
205.91N/AN/AUnspecified myeloid leukemia, in remission
205.92N/AN/AUnspecified myeloid leukemia, in relapse
206.00N/AN/AAcute monocytic leukemia, without mention of having achieved remission
206.01N/AN/AAcute monocytic leukemia,in remission
206.02N/AN/AAcute monocytic leukemia, in relapse
206.10N/AN/AChronic monocytic leukemia, without mention of having achieved remission
206.11N/AN/AChronic monocytic leukemia, in remission
206.12N/AN/AChronic monocytic leukemia, in relapse
206.20N/AN/ASubacute monocytic leukemia, without mention of having achieved remission
206.21N/AN/ASubacute monocytic leukemia, in remission
206.22N/AN/ASubacute monocytic leukemia, in relapse
206.80N/AN/AOther monocytic leukemia, without mention of having achieved remission
206.81N/AN/AOther monocytic leukemia, in remission
206.82N/AN/AOther monocytic leukemia, in relapse
206.90N/AN/AUnspecified monocytic leukemia, without mention of having achieved remission
206.91N/AN/AUnspecified monocytic leukemia, in remission
206.92N/AN/AUnspecified monocytic leukemia, in relapse
207.00N/AN/AAcute erythremia and erythroleukemia, without mention of having achieved remission
207.01N/AN/AAcute erythremia and erythroleukemia, in remission
207.02N/AN/AAcute erythremia and erythroleukemia, in relapse
207.10N/AN/AChronic erythremia, without mention of having achieved remission
207.11N/AN/AChronic erythremia, in remission
207.12N/AN/AChronic erythremia, in relapse
207.20N/AN/AMegakaryocytic leukemia, without mention of having achieved remission
207.21N/AN/AMegakaryocytic leukemia, in remission
207.22N/AN/AMegakaryocytic leukemia, in relapse
207.80N/AN/AOther specified leukemia, without mention of having achieved remission
207.81N/AN/AOther specified leukemia, in remission
207.82N/AN/AOther specified leukemia, in relapse
208.00N/AN/AAcute leukemia of unspecified cell type, without mention of having achieved remission
208.01N/AN/AAcute leukemia of unspecified cell type, in remission
208.02N/AN/AAcute leukemia of unspecified cell type, in relapse
208.10N/AN/AChronic leukemia of unspecified cell type, without mention of having achieved remission
208.11N/AN/AChronic leukemia of unspecified cell type, in remission
208.12N/AN/AChronic leukemia of unspecified cell type, in relapse
208.20N/AN/ASubacute leukemia of unspecified cell type, without mention of having achieved remission
208.21N/AN/ASubacute leukemia of unspecified cell type, in remission
208.22N/AN/ASubacute leukemia of unspecified cell type, in relapse
208.80N/AN/AOther leukemia of unspecified cell type, without mention of having achieved remission
208.81N/AN/AOther leukemia of unspecified cell type, in remission
208.82N/AN/AOther leukemia of unspecified cell type, in relapse
208.90N/AN/AUnspecified leukemia, without mention of having achieved remission
208.91N/AN/AUnspecified leukemia, in remission
208.92N/AN/AUnspecified leukemia, in relapse
209.00N/AN/AMalignant carcinoid tumor of the small intestine, unspecified portion
209.01N/AN/AMalignant carcinoid tumor of the duodenum
209.02N/AN/AMalignant carcinoid tumor of the jejunum
209.03N/AN/AMalignant carcinoid tumor of the ileum
209.10N/AN/AMalignant carcinoid tumor of the large intestine, unspecified portion
209.11N/AN/AMalignant carcinoid tumor of the appendix
209.12N/AN/AMalignant carcinoid tumor of the cecum
209.13N/AN/AMalignant carcinoid tumor of the ascending colon
209.14N/AN/AMalignant carcinoid tumor of the transverse colon
209.15N/AN/AMalignant carcinoid tumor of the descending colon
209.16N/AN/AMalignant carcinoid tumor of the sigmoid colon
209.17N/AN/AMalignant carcinoid tumor of the rectum
209.20N/AN/AMalignant carcinoid tumor of unknown primary site
209.21N/AN/AMalignant carcinoid tumor of the bronchus and lung
209.22N/AN/AMalignant carcinoid tumor of the thymus
209.23N/AN/AMalignant carcinoid tumor of the stomach
209.24N/AN/AMalignant carcinoid tumor of the kidney
209.25N/AN/AMalignant carcinoid tumor of foregut, not otherwise specified
209.26N/AN/AMalignant carcinoid tumor of midgut, not otherwise specified
209.27N/AN/AMalignant carcinoid tumor of hindgut, not otherwise specified
209.29N/AN/AMalignant carcinoid tumor of other sites
209.30N/AN/AMalignant poorly differentiated neuroendocrine carcinoma, any site
209.31N/AN/AMerkel cell carcinoma of the face
209.32N/AN/AMerkel cell carcinoma of the scalp and neck
209.33N/AN/AMerkel cell carcinoma of the upper limb
209.34N/AN/AMerkel cell carcinoma of the lower limb
209.35N/AN/AMerkel cell carcinoma of the trunk
209.36N/AN/AMerkel cell carcinoma of other sites
209.70N/AN/ASecondary neuroendocrine tumor, unspecified site
209.71N/AN/ASecondary neuroendocrine tumor of distant lymph nodes
209.72N/AN/ASecondary neuroendocrine tumor of liver
209.73N/AN/ASecondary neuroendocrine tumor of bone
209.74N/AN/ASecondary neuroendocrine tumor of peritoneum
209.75N/AN/ASecondary Merkel cell carcinoma
209.79N/AN/ASecondary neuroendocrine tumor of other sites
235.0N/AN/ANeoplasm of uncertain behavior of major salivary glands
235.1N/AN/ANeoplasm of uncertain behavior of lip, oral cavity, and pharynx
235.2N/AN/ANeoplasm of uncertain behavior of stomach, intestines, and rectum
235.3N/AN/ANeoplasm of uncertain behavior of liver and biliary passages
235.4N/AN/ANeoplasm of uncertain behavior of retroperitoneum and peritoneum
235.5N/AN/ANeoplasm of uncertain behavior of other and unspecified digestive organs
235.6N/AN/ANeoplasm of uncertain behavior of larynx
235.7N/AN/ANeoplasm of uncertain behavior of trachea, bronchus, and lung
235.8N/AN/ANeoplasm of uncertain behavior of pleura, thymus, and mediastinum
235.9N/AN/ANeoplasm of uncertain behavior of other and unspecified respiratory organs
236.0N/AN/ANeoplasm of uncertain behavior of uterus
236.1N/AN/ANeoplasm of uncertain behavior of placenta
236.2N/AN/ANeoplasm of uncertain behavior of ovary
236.3N/AN/ANeoplasm of uncertain behavior of other and unspecified female genital organs
236.4N/AN/ANeoplasm of uncertain behavior of testis
236.5N/AN/ANeoplasm of uncertain behavior of prostate
236.6N/AN/ANeoplasm of uncertain behavior of other and unspecified male genital organs
236.7N/AN/ANeoplasm of uncertain behavior of bladder
236.90N/AN/ANeoplasm of uncertain behavior of urinary organ, unspecified
236.91N/AN/ANeoplasm of uncertain behavior of kidney and ureter
236.99N/AN/ANeoplasm of uncertain behavior of other and unspecified urinary organs
237.0N/AN/ANeoplasm of uncertain behavior of pituitary gland and craniopharyngeal duct
237.1N/AN/ANeoplasm of uncertain behavior of pineal gland
237.2N/AN/ANeoplasm of uncertain behavior of adrenal gland
237.3N/AN/ANeoplasm of uncertain behavior of paraganglia
237.4N/AN/ANeoplasm of uncertain behavior of other and unspecified endocrine glands
237.5N/AN/ANeoplasm of uncertain behavior of brain and spinal cord
237.6N/AN/ANeoplasm of uncertain behavior of meninges
237.70N/AN/ANeurofibromatosis, unspecified
237.71N/AN/ANeurofibromatosis, type 1 [von recklinghausen's disease]
237.72N/AN/ANeurofibromatosis, type 2 [acoustic neurofibromatosis]
237.73N/AN/ASchwannomatosis
237.79N/AN/AOther neurofibromatosis
237.9N/AN/ANeoplasm of uncertain behavior of other and unspecified parts of nervous system
238.0N/AN/ANeoplasm of uncertain behavior of bone and articular cartilage
238.1N/AN/ANeoplasm of uncertain behavior of connective and other soft tissue
238.2N/AN/ANeoplasm of uncertain behavior of skin
238.3N/AN/ANeoplasm of uncertain behavior of breast
238.4N/AN/APolycythemia vera
238.5N/AN/ANeoplasm of uncertain behavior of histiocytic and mast cells
238.6N/AN/ANeoplasm of uncertain behavior of plasma cells
238.71N/AN/AEssential thrombocythemia
238.72N/AN/ALow grade myelodysplastic syndrome lesions
238.73N/AN/AHigh grade myelodysplastic syndrome lesions
238.74N/AN/AMyelodysplastic syndrome with 5q deletion
238.75N/AN/AMyelodysplastic syndrome, unspecified
238.76N/AN/AMyelofibrosis with myeloid metaplasia
238.77N/AN/APost-transplant lymphoproliferative disorder (PTLD)
238.8N/AN/ANeoplasm of uncertain behavior of other specified sites
238.9N/AN/ANeoplasm of uncertain behavior, site unspecified
239.0N/AN/ANeoplasm of unspecified nature of digestive system
239.1N/AN/ANeoplasm of unspecified nature of respiratory system
239.2N/AN/ANeoplasm of unspecified nature of bone, soft tissue, and skin
239.3N/AN/ANeoplasm of unspecified nature of breast
239.4N/AN/ANeoplasm of unspecified nature of bladder
239.5N/AN/ANeoplasm of unspecified nature of other genitourinary organs
239.6N/AN/ANeoplasm of unspecified nature of brain
239.7N/AN/ANeoplasm of unspecified nature of endocrine glands and other parts of nervous system
239.81N/AN/ANeoplasms of unspecified nature, retina and choroid
239.89N/AN/ANeoplasms of unspecified nature, other specified sites
239.9N/AN/ANeoplasm of unspecified nature, site unspecified
Legend:
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.

More information on these alternative reporting mechanisms is available at:
    http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.